EverettEVokesMD

Clinical Trials

• Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer Start of enrollment: 1996 Jun 01

  Completed

  Phase 2

• Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery Start of enrollment: 1998 Jul 01

  Completed

  Phase 3

• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer Start of enrollment: 1999 Oct 01

  Completed

  Phase 1, Phase 2

• ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck Start of enrollment: 2001 Mar 01

  Completed

  Phase 2

• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Start of enrollment: 2001 Jul 01

  Completed

  Phase 1

• Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) Start of enrollment: 2004 Nov 01

  Completed

  Phase 3

• A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck Start of enrollment: 2004 Jan 01

  Completed

  Phase 2

• Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer Start of enrollment: 2006 Jun 01

  Terminated

  Phase 1

• Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Start of enrollment: 2006 Jul 01

  Completed

  Phase 2

• Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck Cancer

  Completed

  Phase 1, Phase 2

• The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2009 Apr 01

  Terminated

  Phase 2

• Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC Start of enrollment: 2010 Mar 01

  Completed

  Not Applicable

• Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC Start of enrollment: 2010 Feb 01

  Terminated

  Phase 1

• Cetuximab and Lenalidomide in Head and Neck Start of enrollment: 2010 Feb 01

  Completed

  Phase 2

• Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer Start of enrollment: 2003 Jan 27

  Completed

  Phase 2

• Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck Cancer Start of enrollment: 2003 Mar 01

  Completed

• Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) Start of enrollment: 2014 May 29

  Completed

  Phase 3

• Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25

  Completed

  Phase 2

• Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01

  Completed

  Phase 2

• Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01

  Completed

  Phase 2, Phase 3

• Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29

  Active, not recruiting

  Phase 3

• De-Escalation Therapy for Human Papillomavirus Negative Disease Start of enrollment: 2019 Aug 26

  Recruiting

  Phase 2

• Join now to see all